Hypoglycemic agent 3
Hypoglycemic agent 3 (Compound H26), a derivative of corosolic acid, exhibits lipid-lowering and significant hypoglycemic effects and can be used as a hypoglycemic agent. Hypoglycemic agent 3 inhibits insulin resistance by targeting MCCC1 and can be used in the study of type 2 diabetes[1].
Product Specifications
UNSPSC
12352211
Target
Akt; NF-κB; PI3K
Related Pathways
NF-κB; PI3K/Akt/mTOR
Field of Research
Metabolic Disease
Smiles
O=C(O)CNC([C@]12CC[C@@H](C)[C@H](C)[C@@]1([H])C3=CCC4[C@@]5(C)C[C@@H](O)[C@H](O)C(C)(C)C5CC[C@@]4(C)[C@]3(C)CC2)=O
Molecular Formula
C32H51NO5
Molecular Weight
529.75
References & Citations
[1]Huang G, et al. Corosolic acid and its derivatives targeting MCCC1 against insulin resistance and their hypoglycemic effect on type 2 diabetic mice[J]. European Journal of Medicinal Chemistry, 2024: 117184.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6493768-01 0.2 mL
PDGFA, NT (Platelet-derived Growth Factor Subunit A, PDGF Subunit A, Platelet-derived Growth Factor A Chain, Platelet-derived Growth Factor alpha Polypeptide, PDGF-1, PDGF1) (APC)
Ask
View Details MBS6493768-02 5x 0.2 mL
PDGFA, NT (Platelet-derived Growth Factor Subunit A, PDGF Subunit A, Platelet-derived Growth Factor A Chain, Platelet-derived Growth Factor alpha Polypeptide, PDGF-1, PDGF1) (APC)
Ask
View Details